Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)



Status:Archived
Conditions:Women's Studies
Therapuetic Areas:Reproductive
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:December 2008
End Date:December 2009

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Efficacy and Tolerability of Subcutaneous Progesterone (IBSA) Versus Vaginal Progesterone for Luteal Phase Support in Patients Undergoing In Vitro Fertilization (IVF)


Prospective, open, randomized, parallel, multicenter, two-arm trial to evaluate the efficacy
and tolerability of a new progesterone formulation to be used for luteal support in IVF
(Progesterone-IBSA) administered subcutaneously at a daily dose of 25 mg versus Progesterone
tablets administered intravaginally at 100 mg twice daily for a total dose of 200 mg.



We found this trial at
8
sites
Stanford Clinical Research Center
Stanford, California 94305
?
mi
from
Stanford, CA
Click here to add this to my saved trials
Center for Assisted Reproduction
Bedford, Texas 76022
?
mi
from
Bedford, TX
Click here to add this to my saved trials
Idaho Center for Reproductive Medicine
Boise, Idaho 83702
?
mi
from
Boise, ID
Click here to add this to my saved trials
Center for Reproductive Medicine
Orlando, Florida 32804
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Reproductive Partners Medical Group, Inc.
Redondo Beach, California 90277
?
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Fertility Physicians of Northern California
San Jose, California 95124
?
mi
from
San Jose, CA
Click here to add this to my saved trials
Seattle Reproductive Medicine
Seattle, Washington 98109
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Fertility and Surgical Associates of California
Thousand Oaks, California 91360
?
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials